Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birk Poller

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Archives of Toxicology|July 18, 2024
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC)Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Micromachines|January 8, 2025
Intestinal Cells-on-Chip for Permeability StudiesMarit Keuper-Navis, Hossein Eslami Amirabadi, Joanne Donkers, et al.
Pharmacological Research|July 20, 2023
The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug developmentMarit Keuper-Navis, Markus Walles, Birk Poller, et al.
Clinical and Translational Science|February 26, 2024
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trialChristian Loesche, Damien Picard, Benjamin Van Hoorick, et al.
Molecular Pharmaceutics|June 15, 2026
Quantifying Transporter Activity: An Absolute Scaling Approach Using DigoxinMaïlys De Sousa Mendes, Venkatesh Pilla-Reddy, Hong Shen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Archives of Toxicology|July 18, 2024
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC)Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Micromachines|January 8, 2025
Intestinal Cells-on-Chip for Permeability StudiesMarit Keuper-Navis, Hossein Eslami Amirabadi, Joanne Donkers, et al.
Pharmacological Research|July 20, 2023
The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug developmentMarit Keuper-Navis, Markus Walles, Birk Poller, et al.
Clinical and Translational Science|February 26, 2024
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trialChristian Loesche, Damien Picard, Benjamin Van Hoorick, et al.
Molecular Pharmaceutics|June 15, 2026
Quantifying Transporter Activity: An Absolute Scaling Approach Using DigoxinMaïlys De Sousa Mendes, Venkatesh Pilla-Reddy, Hong Shen, et al.
Pageof 4